CMIC Holdings Co Ltd
TSE:2309
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 621
999 999.9999
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
CMIC Holdings Co Ltd
CMIC Holdings Co Ltd
Cost of Revenue
CMIC Holdings Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cost of Revenue
-¥72.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
C
|
Chiome Bioscience Inc
TSE:4583
|
Cost of Revenue
-¥269.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
|
|
Precision System Science Co Ltd
TSE:7707
|
Cost of Revenue
-¥3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Medinet Co Ltd
TSE:2370
|
Cost of Revenue
-¥624.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
CellSource Co Ltd
TSE:4880
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
WDB coco Co Ltd
TSE:7079
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
CMIC Holdings Co Ltd
Glance View
CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.
See Also
What is CMIC Holdings Co Ltd's Cost of Revenue?
Cost of Revenue
-72.3B
JPY
Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Cost of Revenue amounts to -72.3B JPY.
What is CMIC Holdings Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%
Over the last year, the Cost of Revenue growth was 16%. The average annual Cost of Revenue growth rates for CMIC Holdings Co Ltd have been -6% over the past three years , -5% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
